CBD: good to put a name to a face.
I think 2017 genuinely has the possibility of an excellent year for all SUDA SH's.
As CBD noted Pfizer would be brave not to buy in, assuming the rabbit trial goes well. Then they will want a human trial, but that should be in house and rapid.
By this time next year ArtiMist trade saled and SUD 003 gone. And maybe the new F4 technology sold as well. And all for big$$. That's my prediction anyway.
Hang in there SH and look forward, not back into the past. This stuff is potentially huge.
Ann: AGM presentation, page-18
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.025(15.6%) |
Mkt cap ! $194.5M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 19.0¢ | 16.0¢ | $1.303M | 7.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 167000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 349887 | 3 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |